Cosmetic composition of the oil-in-water emulsion type with a powdery appearance

Abstract

L'OREAL "Cosmetic composition of oil-in-water emulsion type with powdery perception" The present invention relates to a composition, preferably cosmetic, in the form of an oil-in-water emulsion, comprising: (a) at least one hydrophilic silica; (b) at least squalane; (c) at least one alkane oil with a molecular weight less than or equal to 200 g / mol and (d) at least one C6-C30 fatty alcohol, liquid at room temperature). It also relates to a cosmetic treatment process in which said composition is applied to a keratin material and the use of said composition in the cosmetic field, and in particular for the care and / or protection of the skin of the body or face. Figure for the abstract: None

Description

Title of the invention: Cosmetic composition of the oil-in-water emulsion type with a powdery appearance Technical field

[0001] The present invention relates to the field of cosmetic care compositions, in particular in the form of oil-in-water emulsions, and providing interesting sensory properties when applied and dried on a keratin material.

[0002] By “keratin material” is meant in particular the skin, the scalp, keratin fibers such as the eyelashes, the eyebrows, the hair, and the body hair, the nails, the mucous membranes such as the lips, and more particularly the skin (body, face, neck, décolleté, eye contour, eyelids). Prior art

[0003] The galenic forms conventionally used to provide a powdery feel are solid compositions comprising powdery materials such as loose or pressed powders, the latter also being called compact. These galenic forms are particularly appreciated by users, given their lightness, softness and non-sticky or greasy feel.

[0004] This type of powdery feel composition also exists in the form of a direct emulsion, namely an oily phase dispersed in an aqueous phase. These compositions have the advantage of providing a similar or even more suitable sensoriality for skin care and, above all, of providing a perception of freshness and comfort upon application. They are also conducive to rapid evaporation of the liquid medium carrying the powdery materials.

[0005] On the other hand, with regard to these direct emulsion type compositions, there is a need to maintain their stability, in particular by limiting the phase shift phenomenon after manufacture, when particulate materials, such as powdery materials, are incorporated therein at a high charge rate. Among the particulate materials of these compositions generally are materials such as hydrophobic silicas and / or lauroyl lysine type particles, of a lipophilic nature. Due to their lack of affinity or low affinity for water, these particulate materials have the advantage of being more compatible with the architecture of direct emulsions, but the physicochemical stability of these emulsions does not remain optimal. Furthermore, the galenic formulas incorporating these materials do not provide users with an immediate perception of marked, soft and slippery powderiness, in particular during its drying and / or after drying on the skin.But this is precisely what users expect.

[0006] Furthermore, with regard to these direct emulsion type compositions, there is a need to improve their appearance on the skin after application, in particular by limiting the formation of white traces on the skin, in particular when particulate materials, such as powdery materials, are incorporated therein at a high charge rate.

[0007] Thus, the present invention aims to develop a galenic formula capable of providing users with an almost immediate perception of powderiness upon application.

[0008] It also aims to offer a composition providing its users with feelings of lightness, softness and a non-sticky or greasy appearance to the touch.

[0009] It also aims to provide a composition whose appearance after application to the skin is improved, in particular for which the formation of white traces on the surface of the skin after application is limited or even avoided.

[0010] Finally, the invention also aims to propose a galenic formula with a better carbon footprint, in particular by promoting the use of renewable raw materials and / or with a good index of naturalness and / or of natural and / or abundant origin. Indeed, the formulation of environmentally friendly cosmetic products, that is to say, the design and development of which take environmental issues into account, is becoming a major concern to help meet global challenges. It is therefore essential to propose more sustainable compositions that can thus meet these environmental challenges. Summary of the invention

[0011] Thus, according to one of its aspects, the present invention relates to a composition, preferably cosmetic, in the form of an oil-in-water emulsion, comprising:

[0012] (a) at least one hydrophilic silica;

[0013] (b) at least squalane;

[0014] (c) at least one alkane oil with a molecular weight less than or equal to 200 g / mol; and

[0015] (d) at least one C6-C3o fatty alcohol, liquid at room temperature.

[0016] Against all expectations, the inventors have thus found that a composition according to the invention has a satisfactory appearance on the skin after application, in particular without the formation of white traces on the skin, while exhibiting rapid volatility at the time of application followed by the formation of a deposit after drying, providing a satisfactory sensation of comfort and perception of powderiness.

[0017] According to a particular embodiment, a composition according to the invention comprises:

[0018] - at least 7% by weight of hydrophilic silica(s) (a) relative to the total weight of the composition ;

[0019] - from 5% to 35% by weight of alkane oil(s) (c) relative to the total weight of the com- position, including at least one mixture of C9-C[2] alkane oils;

[0020] - from 0.01% to 20% by weight of squalane (c) relative to the total weight of the composition position; and

[0021] - from 0.01% to 10% by weight of fatty alcohol(s) (d) relative to the total weight of the com position, including at least octyldodecanol.

[0022] More particularly, a composition according to the invention may comprise:

[0023] - from 7% to 35% by weight of hydrophilic silica(s) (a) relative to the total weight of the composition ;

[0024] - from 5% to 35% by weight of alkane oil(s) (c) relative to the total weight of the composition position, including at least one mixture of C9-C[2] alkane oils;

[0025] - from 0.01% to 20% by weight of squalane (c) relative to the total weight of the composition position; and

[0026] - from 0.01% to 10% by weight of fatty alcohol(s) (d) relative to the total weight of the com position, including at least octyldodecanol.

[0027] The present invention also relates to a method for the cosmetic treatment of a keratin material in which a composition as defined above is applied to the keratin material.

[0028] The present invention also relates to a use of a composition as defined above in the cosmetic field, and in particular for the care, protection and / or makeup of the skin of the body or face.

[0029] Other characteristics, aspects and advantages of the invention will appear on reading the detailed description which follows.

[0030] In what follows, the expression “at least one” is equivalent to “one or more” and, unless otherwise indicated, the limits of a domain of values ​​are included in this domain. Detailed description

[0031] The composition according to the invention is cosmetic and / or dermatological, and preferably is cosmetic. By "cosmetic" is meant a composition compatible with the skin, mucous membranes and appendages. The composition according to the invention is non-therapeutic.

[0032] The composition according to the invention is generally suitable for topical application to the skin and therefore generally comprises a physiologically acceptable medium, i.e. compatible with the skin.

[0033] It is preferably a cosmetically acceptable medium, that is to say which has a pleasant color, odor and feel and does not generate unacceptable discomfort, that is to say tingling, tightness, redness, likely to discourage the user from applying this composition.

[0034] According to a particular embodiment, the composition according to the invention comprises less than 1.0% by weight, in particular less than 0.5% by weight of silicone compound(s) relative to the total weight of the composition, and more particularly free of silicone compound(s).

[0035] For the purposes of the present invention, the term "silicone compound" means a compound belonging to the family of siloxanes or polysiloxanes (silicones) known in the field of cosmetics, of formula R2SiO or [SiOR2]n, in which R is an organic group, for example alkyl. A silicone compound is, for example, chosen from silicone oils, silicone surfactants, silicone resins, and mixtures thereof. Hydrophilic silica (a)

[0036] The composition according to the invention comprises a hydrophilic silica (a).

[0037] According to a particular embodiment, the composition according to the invention comprises an amorphous hydrophilic silica (a).

[0038] An amorphous silica may be natural or synthetic. For example, a synthetic amorphous silica is chosen from microamorphous silicas and mixtures thereof, in particular silica gels, colloidal silicas, precipitated amorphous silicas, pyrogenic silicas and mixtures thereof.

[0039] According to a particular embodiment, the composition according to the invention comprises a hydrophilic silica (a) chosen from silicas having an average particle diameter ranging from 1 pm to 30 pm, in particular from 1 pm to 25 pm, and more particularly from 1 pm to 20 pm.

[0040] Such an average particle diameter can be characterized, for example, by means of an apparatus using the Coulter principle and in particular the Multisizer™ apparatus marketed by the company Beckman Coulter.

[0041] As hydrophilic silica (a), we can cite: the compound with the INCI name “SILICA”, marketed under the name SOLESPHERE™ H51 by the company AGC Chemicals Americas or SUNSPHERE® H51 by the company AGC SI TECH.

[0042] According to one embodiment, the composition according to the invention comprises at least 7% by weight, in particular at least 10% by weight, more particularly at least 12% by weight, and even more particularly 14% by weight of hydrophilic silica(s) (a) relative to the total weight of the composition.

[0043] According to another embodiment, the composition comprises from 7% to 35% by weight, in particular from 7% to 30% by weight, and more particularly from 10% to 25% by weight of hydrophilic silica(s) relative to the total weight of the composition. Squalane (b)

[0044] In particular, the squalane present in a composition according to the invention may be of plant origin, for example squalane marketed under the name EXOLIVE® by the company CAROI LINE COSMETICA, under the name OLIVE SQUALANE by the company EFP BIOTEK, under the name PLANTASENS® OLIVE SQUALANE by the company CLARIANT or under the name SQUALIVE® by the company BIOSYNTHIS.

[0045] The composition according to the invention may comprise from 0.01% to 20% by weight, preferably from 0.1% to 15% by weight, and more preferably from 0.5% to 10% by weight of squalane (b) relative to the total weight of the composition. Alkane oil(s) (c)

[0046] The alkane oil suitable for a composition according to the invention has a molecular weight less than or equal to 200 g / mol.

[0047] For the purposes of the invention, the term "oil" means a non-aqueous compound, immiscible with water, liquid at room temperature (20°C + / - 5°C) and atmospheric pressure (760 mm Hg).

[0048] The alkane oils (c) suitable for the invention are more particularly of vegetable, mineral or synthetic origin. These alkane oils are volatile or non-volatile.

[0049] More particularly, a composition according to the invention contains at least one alkane oil (c) chosen from linear or branched alkane oils, in particular linear alkane oils and their mixtures.

[0050] In a particular embodiment of the invention, the alkane oil (c) may be chosen from C6 to C14 alkane oils, preferably C8 to C12 alkane oils, more preferably C9 to C12 alkane oils, and in particular C9 to C12 alkane oils.

[0051] Advantageously, the alkane oil (c) may have a molecular weight less than or equal to 190 g / mol.

[0052] According to a particular embodiment, the alkane oil (c) may be present in the form of a mixture of alkane oils (c) with a molecular weight less than or equal to 200 g / mol.

[0053] In particular, the alkane oil (c) may comprise at least one mixture of C6-Ci4 alkane oils, in particular C8-Cn alkane oils, more particularly C9-Cb alkane oils, and in particular C9-Ci2 alkane oils.

[0054] For the purposes of the invention, the term “mixture of C6-Ci4 alkane oils” is intended to cover any mixture containing a C6, C7, C8, C9, C10, Cn, C12, Cn and C[4 alkane oil.

[0055] As an example of alkane oil (c), we can cite:

[0056] - branched C8-CM alkane oils, such as iso-alkanes (also called isopa C8-Ci4 refined oils, for example isododecane and isodecane, in particular in the form of a mixture of iso-alkanes with or without ancillary alkane oil(s), such as oils sold under the trade names Isopars or Permetyls®;

[0057] - linear C6-Ci4 alkane oils, in particular in the form of a mixture of linear C6-C14 alkane oils such as the undecane-tridecane mixture, the mixtures of n-undecane (Cn) and n-tridecane (Cn) obtained in examples 1 and 2 of application WO 2008 / 155059 from Cognis, and the mixture of C9-C12 alkane oils (INCI name: C9-12 ALKANE) for example marketed under the reference VEGELIGHT® SILK 100 by BIOSYNTHIS.

[0058] The composition according to the invention may comprise from 5% to 35% by weight, preferably from 5% to 25% by weight, more preferably from 5% to 20% by weight, and in particular from 5% to 15% by weight of alkane oil(s) (c) relative to the total weight of the composition.

[0059] Fatty alcohol(s) in QC^, liquid(s) at room temperature (d)

[0060] The composition according to the invention comprises at least one C6-C30 fatty alcohol, liquid at room temperature.

[0061] For the purposes of the invention, the term “ambient temperature” means a temperature equal to 20°C + / - 5°C, in particular 25°C, at atmospheric pressure (760 mm Hg).

[0062] The fatty alcohols (d) suitable for a composition according to the invention may be saturated or unsaturated, in particular saturated.

[0063] Furthermore, such fatty alcohols (d) according to the invention may be linear or branched, in particular branched.

[0064] Furthermore, such fatty alcohols (d) according to the invention may be primary, secondary or tertiary, in particular are primary.

[0065] Preferably, the fatty alcohol (d) is neither oxyalkylenated nor glycerolated.

[0066] According to a particular embodiment, the fatty alcohol (d) present in the composition in accordance with the invention may be chosen from branched-chain primary fatty alcohols and their mixtures.

[0067] By "saturated fatty alcohol" is meant any alcohol comprising a saturated hydrocarbon chain (without covalent double or triple bond), in particular a linear or branched alkyl radical, said chain comprising between 6 and 30 carbon atoms and a hydroxyl function, it being understood that such an alcohol is liquid at room temperature. By "unsaturated fatty alcohol" is meant any alcohol comprising an unsaturated hydrocarbon chain (with at least one covalent double and / or triple bond), in particular a linear or branched alkenyl or alkynyl radical, said chain comprising between 6 and 30 carbon atoms and a hydroxyl function, it being understood that such an alcohol is liquid at room temperature.

[0068] For the purposes of the invention, the term “hydrocarbon chain” means an organic group consisting mainly or even exclusively of hydrogen atoms and carbon atoms. This chain is particularly free of silicon atoms and therefore not silicone-containing.

[0069] According to a particular embodiment, the fatty alcohol (d) present in the composition in accordance with the invention may be chosen from C16-C22 fatty alcohols and their mixtures, and in particular from C18-C20 fatty alcohols and their mixtures.

[0070] According to a particular embodiment, the fatty alcohol (d) present in the composition in accordance with the invention can be used in the form of a mixture of liquid fatty alcohols in C6-C30, particularly in C16-C22, and more particularly in C18-C20.

[0071] As fatty alcohols (d) which are liquid at room temperature, mention may be made, for example, of: octyldodecanol (C20) sold under the name EUTANOL® G, EUTANOL® G-JP or EUTANOL® G / MB by the company BASF or under the name ISOFOL® 20 by the company SASOL, undecylenic alcohol (Cn), 2-butyloctanol (Ci2), 2-hexyldecanol (Ci6), ricinoleic alcohol (Ci8), oleyl alcohol (Ci8), linoleic alcohol (Ci8), 2-undecylpentadecanol (C26), and preferably octyldodecanol.

[0072] According to a particular embodiment, the composition according to the invention may comprise from 0.01% to 15% by weight, preferably from 0.1% to 5% by weight, and in particular from 0.5% to 2% by weight of fatty alcohol(s) (d) relative to the total weight of the composition.

[0073] Distinct volatile compound(s) of an alkane oil (cl

[0074] The composition according to the invention may, in addition, contain at least one volatile compound chosen from C1-C5 monoalcohols, C8-C16 volatile ester oils, C8-C16 volatile ether oils, C8-C16 volatile carbonic acid ester oils, C8-C16 volatile ketone oils, C8-C16 volatile aldehyde oils, and mixtures thereof.

[0075] According to a particular embodiment, a composition according to the invention may comprise at least one C1-C5 monoalcohol.

[0076] The term “C1-C5 monoalcohols” means alcohols comprising a single hydroxyl function, linear or branched, and having from 1 to 5 carbon atoms.

[0077] The C1-C5 monoalcohols are, for example, ethanol, propanol such as for example n-propanol and isopropanol, butanol, pentanol, hexanol, isopropyl alcohol, cyclohexanol, isobutyl alcohol and 2-methyl-2-butanol (2-methylbutan-2-ol).

[0078] In particular, the composition according to the invention may comprise at least one C1-C5 monoalcohol, and in particular ethanol.

[0079] More particularly, a composition according to the invention may comprise from 0.1% to 10% by weight, preferably from 0.1% to 7% by weight, and more preferably from 0.5% to 5% by weight of C1-C5 monoalcohol(s), in particular including ethanol, relative to the total weight of the composition.

[0080] According to a particular embodiment, a composition according to the invention may comprise at least one oil chosen from:

[0081] - volatile C8-Ci6 ester oils, particularly linear or branched esters in C8-Cn;

[0082] - volatile C8-Ci6 ether oils, particularly linear or branched ethers in C10-C13;

[0083] - volatile oils C8-Ci6 carbonic acid esters, particularly esters linear or branched C8-Ci0 carbonic acids;

[0084] - volatile C8-Ci6 ketone oils, particularly linear ketones or branched in C9-Ci2;

[0085] - volatile C8-Ci6 aldehyde oils, particularly linear aldehydes or branched in C8-Cn; and

[0086] - their mixtures.

[0087] For the purposes of the invention, the term "volatile oil" means any volatile oil, preferably non-silicone, capable of evaporating on contact with the skin or a keratinous fiber in less than one hour, at room temperature and atmospheric pressure. The volatile oil(s) are liquid at room temperature (20°C) and atmospheric pressure (760 mm Hg), in particular having a non-zero vapor pressure at room temperature and atmospheric pressure, in particular having a vapor pressure ranging from 0.13 Pa to 40,000 Pa (103 to 300 mm Hg), in particular ranging from 1.3 Pa to 13,000 Pa (0.01 to 100 mm Hg), and more particularly ranging from 1.3 Pa to 1,300 Pa (0.01 to 10 mm Hg).

[0088] According to a particular embodiment, the composition comprises at least one volatile ester oil, in particular chosen from linear or branched C8-C16 esters, more particularly branched C8-C16 esters, such as for example isohexyl neo-pentanoate, and mixtures thereof.

[0089] According to another particular embodiment, the composition comprises at least one volatile ether oil, in particular chosen from volatile C8-Ci6 ethers, more particularly linear or branched C10-Ci3 esters, and mixtures thereof.

[0090] Among the volatile ethers, we can cite:

[0091] - linear ethers in Cio or Cn,

[0092] - saturated and branched Cio or Cn ethers, and

[0093] - branched ethers in Ci2 or Cn.

[0094] According to another particular embodiment, the composition comprises at least one volatile carbonic acid ester oil, in particular chosen from volatile C8-Ci6 carbonic acid esters, more particularly linear or branched C8-Ci0 carbonic acid esters, and mixtures thereof.

[0095] Among the volatile carbonic acid ester oils, we can cite:

[0096] - carbonic acid esters, linear or branched in C8, and

[0097] - C9 branched carbonic acid esters.

[0098] According to another particular embodiment, the composition comprises at least one volatile ketone oil, in particular chosen from volatile C8-C16 ketones, more particularly linear or branched C9-C12 ketones, and mixtures thereof.

[0099] Among the volatile ketone oils, we can cite:

[0100] - ketones, linear or branched, in C9 or C10, and

[0101] - branched ketones in Cn or Ci2.

[0102] According to another particular embodiment, the composition comprises at least one volatile aldehyde oil, in particular chosen from volatile C8-C16 aldehydes, more particularly linear or branched C8-Cn aldehydes, and mixtures thereof.

[0103] Among the volatile aldehydes, we can cite:

[0104] - linear C8 or C9 aldehydes, and

[0105] - branched aldehydes in C9 or Cn. Surfactant(s)

[0106] The composition according to the invention may comprise at least one surfactant comprising at least one C2-C14 hydrocarbon chain, linear or branched and more preferably linear.

[0107] As surfactant comprising at least one C2-Ci4 hydrocarbon chain which can be used in a composition according to the invention, the following surfactants and their mixtures can be cited: i) Alkyl(poly)glycosides

[0108] According to one embodiment, the composition according to the invention may comprise at least one surfactant chosen from alkyl(poly)glycosides comprising at least one C2-Ci4 hydrocarbon chain, and mixtures thereof.

[0109] For the purposes of the present invention, the term “alkyl(poly)glycoside” means an alkyl-monooside (degree of polymerization equal to 1) or alkylpolyoside (degree of polymerization greater than 1), and their derivatives such as anionic derivatives of alkyl(poly)glycoside.

[0110] In particular, the alkyl(poly)glycosides of formula (I): [YES] [Chem.l] RO-(G)a (I)

[0112] in which

[0113] - the radical R denotes a linear or branched C2-Ci4 alkyl radical, preferably radical R is C8-Ci3, more preferably C8-Ci2, in particular C10-Ci2, for example C10;

[0114] - group G is a saccharide residue; and

[0115] - a, being the degree of polymerization, is a number ranging from 1 to 10, preferably 1 to 5, especially 1 to 3.

[0116] According to a particular embodiment of the invention, the radical R denotes a linear C8-Ci4 alkyl radical, preferably C8-Ci2, more preferably C10-Ci2.

[0117] According to another particular embodiment of the invention, the saccharide residue G may be chosen from glucose, dextrose, sucrose, fructose, galactose, maltose, maltotriose, lactose, cellobiose, mannose, ribose, dextran, talose, allose, xylose, levoglucan, cellulose or starch. More preferably, the saccharide residue G denotes at least one glucose unit. In particular, each unit of the (poly)oside part of the alkyl(poly)glycoside may be in isometric form α or β, in L or D form and the configuration of the saccharide residue may be of furanoside or pyranoside type. The degree of polymerization, i.e. the value of a in formula (I), can range from 1 to 3. The average degree of polymerization is more particularly between 1 and 2.5, preferably from 1.05 to 2.5, and more preferably from 1.1 to 2.

[0118] It is of course possible to use mixtures of alkyl(poly)osides, each alkyl(poly)osides being capable of differing from one another by the nature of the alkyl unit carried and / or the nature of the carrying polysaccharide chain.

[0119] Examples of alkyl(poly)glycosides include:

[0120] - decyl glucoside such as the product marketed under the name Mydol 10® by Kao Chemicals or the product marketed under the name Plantacare 2000 UP® by BASF or the product marketed under the name ORAMIX NS 10® by SEPPIC;

[0121] - caprylyl / capryl glucoside as the product marketed under the name Plantacare KE 3711® by the company Cognis or ORAMIX CG 110® by the company SEPPIC;

[0122] - laurylglucoside such as the product marketed under the name Plantacare 1200 UP® by BASF or Plantaren 1200 N® by BASF;

[0123] - cocoglucoside such as the product marketed under the name Plantacare 818 UP® by BASF;

[0124] - methyl coco glucoside marketed under the name Eumulgin GTS by the Cognis company; and

[0125] - caprylylglucoside as the product marketed under the name Plantacare 810 UP® by Cognis.

[0126] According to a particular embodiment of the invention, the composition according to the invention may comprise decyl glucoside (INCI name: DECYL GLUCOSIDE), in particular the product marketed under the name PLANTACARE® 2000 UP by the company BASF.

[0127] The alkyl(poly)glycoside can also be used in a mixture with at least one fatty alcohol, in particular an additional C8-C30 fatty alcohol, and more particularly a C12-C22 fatty alcohol. Preferably, the additional fatty alcohols are R-OH structures with R denoting a linear alkyl group, optionally substituted by one or more hydroxyl groups, comprising from 8 to 30, better still from 10 to 30, or even from 12 to 24 atoms, even better still from 14 to 22 carbon atoms. Such additional fatty alcohols that may be used may be selected from, alone or in mixture, lauryl or lauryl alcohol (1-dodecanol), myristyl or myristyl alcohol (1-tetradecanol), cetyl alcohol (1-hexadecanol), stearyl alcohol (1-octadecanol), arachidyl alcohol (1-eicosanol), behenyl alcohol (1-docosanol), lignoceryl alcohol (1-tetracosanol), ceryl alcohol (1-hexacosanol), montanyl alcohol (1-octacosanol), and myricyl alcohol (1-triacontanol).

[0128] For example, it is possible to jointly use an additional fatty alcohol and an alkyl(poly)glycoside whose alkyl part is identical to that of the additional fatty alcohol selected. The emulsifying mixtures of additional fatty alcohol(s) / alkyl polyglycoside(s) as defined above are known as such. They are described in particular in applications WO 92 / 06778, WO 95 / 13863 and WO 98 / 47610 and prepared according to the preparation processes indicated in these documents. Among the particularly preferred fatty alcohol / alkyl polyglycoside mixtures, mention may be made of the products sold by the company SEPPIC under the names MONTANOV® such as the following mixtures:

[0129] - Cetylstearyl alcohol / Cocoglucoside- MONTANOV 82®;

[0130] - Arachidyl alcohol and behenyl alcohol / arachidylglucoside - MONTANOV 802 ® •

[0131] - Myristyl alcohol / Myristylglucoside - MONTANOV 14®; And

[0132] - Cocoalcool / Coco-glucoside - MONTANOV S®.

[0133] As alkyl(poly)glycosides, mention may also be made of anionic alkyl(poly)glycoside derivatives, such as citrates, tartrates, sulfosuccinates, carbonates and glycerol ethers manufactured from alkyl(poly)glycosides, such as the sodium salt of cocoyl polyglucoside tartaric ester marketed under the name EUCAROL AGE-ET® by the company Cesalpinia, the disodium salt of cocoyl polyglucoside sulfosuccinic ester marketed under the name ESSAI 512 MP® by the company Seppic, the sodium salt of cocoyl polyglucoside citric ester marketed under the name EUCAROL AGE-EC® by the company Cesalpinia, the sodium lauryl polyglucoside ether carboxylate marketed under the name PLANTAPON LGC SORB by the company Cognis. ii) acylamino acids

[0134] According to another embodiment, the composition according to the invention may comprise at least one surfactant chosen from acylamino acids comprising at least one C2-Ci4 hydrocarbon chain and mixtures thereof, in particular alkali salts of N-acylamino acids comprising at least one C2-Ci4 hydrocarbon chain and mixtures thereof.

[0135] The alkali salts are, for example, sodium salts, potassium salts and lithium salts, and preferably sodium salts.

[0136] As alkali salts of N-acylamino acids, we can cite for example:

[0137] - Glycinates, such as sodium cocoylglycinate marketed by the company Ajinomoto under the name Amilite GCS-12®, sodium cocoylglycinate marketed by the company Ajinomoto under the name Amilite GCK-12®.

[0138] - Glutamates, in other words the alkali salts of N-acylglutamic acids, of preferably the alkali salts of acyl (C6-Ci4) glutamic acids. Mention may in particular be made of the alkali salts of lauroyl glutamic acid or cocoyl glutamic acid, such as, for example, disodium cocoyl glutamate marketed by the company Ajinomoto under the name Amisoft ECS-22SB, sodium lauroyl glutamate (INCI name: SODIUM LAUROYL GLUTAMATE) marketed by the company Ajinomoto under the name AMISOFT® LS 11, sodium and disodium stearoyl glutamate marketed by the company Ajinomoto under the names AMISOFT® HS21 P and AMISOFT® HS 11 Pf.

[0139] - Sarcosinates, such as sodium lauroyl sarcosinate marketed by Seppic company under the name ORAMIX L 30® or marketed under the name SARKOSYL NL 97® by Ciba company, sodium cocoyl sarcosinate marketed by ZSCHIMMER & SCHWARZ company under the name Protelan LS 9011 / C, and sodium myristoyl sarcosinate, marketed under the name NIKKOL SARCOSINATE MN® by Nikkol company.

[0140] - Alaninates such as sodium N-lauroyl-N-methylamidopropionate, com marketed under the name SODIUM NIKKOL ALANINATE LN 30® by the company Nikkol or marketed under the name ALANONE ALE®, by the company Kawaken, and N-lauroyl N-methylalanine triethanolamine, marketed under the name ALANONE ALTA® by the company Kawaken.

[0141] - Aspartates such as the mixture of triethanolamine N-lauroylaspartate and N- triethanolamine myristoylaspartate, marketed under the name ASPARACK ® by the Mitsubishi company.

[0142] Mention may also be made of the sodium salt of oat lauroyl amino acids such as Proteol OAT marketed by the company Seppic or the compound bearing the INCI name sodium cocoyl amino acids such as Proteol SAV 5OS from Seppic. iii) geminal surfactants

[0143] According to another embodiment, the composition according to the invention may comprise at least one surfactant chosen from geminal surfactants comprising at least one C2-Ci4 hydrocarbon chain, and mixtures thereof.

[0144] By "geminal surfactant" is meant a surfactant comprising at least two hydrophilic heads linked together by a spacer, and at least two hydrophobic tails, each hydrophobic tail being linked to a hydrophilic head. The spacer may be polar or apolar, flexible or rigid, short or long. The hydrophilic heads may be anionic, cationic or non-ionic. In particular, the geminal surfactant comprises two hydrophilic heads linked together by a spacer, and two hydrophobic tails.

[0145] According to a particular embodiment of the invention, the geminate surfactant comprising at least one C2-Ci4 hydrocarbon chain is chosen from the compounds of formula (II) and their mixtures, as well as their stereoisomers:

[0146] [Chem.2] Y' -CONH -CH ho CH —Y' NH CHgiCHgJj-CONH -CH - At

[0147] in which:

[0148] - Y' independently represents a carboxylic acid group or an alkali salt of a carboxylic acid group, such as a sodium salt of a carboxylic acid group;

[0149] - j 1, kl, j2 and k2 represent an integer such that (j 1, kl, j2, k2) = (2, 0, 2, 0), (2, 0, 0, 2), (0, 2, 2, 0) or (0, 2, 0, 2); and

[0150] -1 represents an integer ranging from 4 to 12, preferably from 6 to 12, and advantageous way from 8 to 12.

[0151] According to a particular embodiment of the invention, in formula (II), 1 represents an integer ranging from 8 to 12, j 1 = j2 = 0, and kl = k2 = 2.

[0152] Preferably, in formula (II), Y' represents -COONa, j 1 = j2 = 0, kl = k2 = 2; and 1 = 10.

[0153] As examples of geminate surfactants of formula (II), mention may be made of sodium di-lauramidoglutamide lysine (INCI Name: SODIUM DILAURAMIDO-GLUTAMIDE LYSINE), and sodium dimyristoylglutamide lysine. In particular, sodium dilauramidoglutamide lysine is used. Sodium dilauramidoglutamide lysine is, for example, marketed by ASAHI KASEI under the names PELLICER™ L-30, PELLICER™ LB-30G and PELLICER™ LB-10.

[0154] The geminal surfactant(s) of formula (II) is (are) described in particular in application WO 2004 / 020394.

[0155] According to another particular embodiment of the invention, the geminate surfactant comprising at least one C2-Ci4 hydrocarbon chain is chosen from the compounds of formula (III), and their mixtures, as well as their stereoisomers:

[0156] [Chem.3]

[0157] in which:

[0158] - Rn and Rio denote, independently of one another, an alkyl radical having from 1 to 14 carbon atoms;

[0159] - Ru denotes a spacer consisting of a linear or branched alkylene chain having from 1 to 14 carbon atoms;

[0160] - X and Y denote, independently of one another, a group -(C2H4O)a-(C3H6 O)bZ where Z denotes a hydrogen atom or a radical -CH2-COOM, -SO3M, -P(O)(OM)2, -C2H4-SO3M, -C3H6-SO3M or -CH2(CHOH)4CH2OH, where M represents H or an alkali or alkaline-earth or ammonium or alkanolammonium ion, a ranges from 0 to 7, b ranges from 0 to 4, and the sum of 2a + 3b being less than or equal to 14; and

[0161] - n ranges from 1 to 10.

[0162] The geminate surfactant of formula (III) is preferably such that each of the groups R12-CO- and R10-CO- comprises from 8 to 14 carbon atoms, and preferably denotes a residue of coconut fatty acids (comprising mainly lauric acid and myristic acid).

[0163] Furthermore, this surfactant is preferably such that, for each of the radicals X and Y, the sum of a and b has an average value ranging from 1 to 11 and a preferred group for Z is the -SO3M group where M is preferably an alkali ion such as a sodium ion.

[0164] The spacer Ru is advantageously made up of a linear C1-C3 alkylene chain, and preferably an ethylene chain (CH2CH2).

[0165] Finally, n is advantageously equal to 1.

[0166] A surfactant of this type is in particular that identified by the INCI name Sodium di-cocoylethylenediamine PEG-15 sulfate, having the following structure:

[0167] [Chem.4] O , Il x(PEG-15)—SO,Ng. cocoyi —C —N CH2 CÎL I “ O

[0168] it being understood that PEG represents the group -CH2CH2O-, and cocoyl represents the residue of coconut fatty acids.

[0169] This surfactant has a molecular structure very close to that of ceramide-3.

[0170] Preferably, the geminate surfactant of formula (III) is used in a mixture with other surfactants, and in particular in a mixture with an ester of a C6-C22 fatty acid (preferably a C14-C20 such as a stearate) and glyceryl, a diester of a C6-C22 fatty acid (preferably a C14-C20 such as a stearate) and citric acid and glycerol (in particular a diester of a C6-C22 fatty acid and glyceryl monocitrate), and a C10-C30 fatty alcohol (preferably behenyl alcohol).

[0171] Advantageously, the composition according to the invention comprises a mixture of Sodium Dicocoylethylenediamine PEG-15 Sulfate, glyceryl stearate, glyceryl monocitrate stearate and behenyl alcohol.

[0172] For example, the geminate surfactant of formula (III) can be used in a mixture with other surfactants in the form of products marketed by the company SASOL under the names CERALUTION®, and in particular the following products:

[0173] - Ceralution® H: Behenyl Alcohol, Glyceryl Stearate, Glyceryl Stearate Citrate and Sodium Dicocoylethylenediamine PEG-15 Sulfate,

[0174] - Ceralution® F: Sodium Lauroyl Lactylate and Sodium Dicocoylethylenediamine PEG-15 Sulfate,

[0175] - Ceralution® ES: Disodium Ethylene Dicocamide PEG-15 Disulfate and Ceteareth- 25, or

[0176] - Ceralution® C: Aqua, Capric / Caprylic triglyceride, Glycerin, Ceteareth-25, Sodium Dicocoylethylenediamine PEG-15 Sulfate, Sodium Lauroyl Lactylate, Behenyl Alcohol, Glyceryl Stearate, Glyceryl Stearate Citrate, Gum Arabia, Xanthan Gum, Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Isobutylparaben (INCI names).

[0177] According to a particular embodiment, a composition according to the invention contains at least one surfactant comprising at least one C2-C14 hydrocarbon chain chosen from:

[0178] (i) alkyl(poly)glycosides, in particular alkyl(poly)glycosides of formula (VI):

[0179] [Chem.5] RO-(G)a (I)

[0180] in which

[0181] - the radical R denotes a linear or branched C2-Ci4 alkyl radical, preferably radical R is C8-Ci3, more preferably C8-Ci2, in particular C10-Ci2, for example C10;

[0182] - group G is a saccharide residue; and

[0183] - a, being the degree of polymerization, is a number ranging from 1 to 10, preferably 1 to 5, especially 1 to 3.

[0184] (ii) acylamino acids, in particular alkali salts of N-acylamino acids, more particularly glutamates, such as sodium lauroyl glutamate;

[0185] (iii) geminal surfactants, in particular geminal surfactants of formula (II) as well as their stereoisomers:

[0186] [Chem.6] Y' CH-jCCHPi -CO NH CH who CH—Y' (CHg)4 NH (0¾ CH3(CH8),-CONH ch (0¾ ¥' (II)

[0187] in which:

[0188] - Y' independently represents a carboxylic acid group or an alkali salt of a carboxylic acid group, such as a sodium salt of a carboxylic acid group;

[0189] - jl, kl, j2 and k2 represent an integer such that (jl, kl, j2, k2) = (2, 0, 2, 0), (2, 0, 0, 2), (0, 2, 2, 0) or (0, 2, 0, 2); and

[0190] -1 represents an integer ranging from 4 to 12, preferably from 6 to 12, and advantageous way from 8 to 12; and

[0191] (iv) their mixtures.

[0192] Preferably, the surfactant comprising at least one hydrocarbon chain in C2-C14 is chosen from mixtures of (i) alkyl(poly)glycoside(s), in particular alkyl(poly)glycoside(s) of formula (I), and (ii) geminal surfactant(s), in particular geminal surfactants of formula (II).

[0193] According to a particular embodiment, the composition according to the invention comprises from 0.05% to 10% by weight, preferably from 0.1% to 8% by weight, and more preferably from 0.2% to 6% by weight of surfactant(s) comprising at least one C2-Ci4 hydrocarbon chain relative to the total weight of the composition.

[0194] According to a particular embodiment, the composition according to the invention comprises from 0.05% to 10% by weight, preferably from 0.1% to 8% by weight, and more preferably from 0.2% to 6% by weight of surfactant(s) comprising at least one C2-Ci4 hydrocarbon chain, including at least the compound with the INCI name: SODIUM DILAU-RAMIDOGLUTAMIDE LYSINE, relative to the total weight of the composition.

[0195] In a particular embodiment, a composition according to the invention may comprise at least one additional surfactant distinct from the surfactant(s) comprising at least one C2-Ci4 hydrocarbon chain.

[0196] As an additional surfactant that can be used in a composition according to the invention, non-ionic surfactant(s) and their mixtures can be cited in particular.

[0197] The nonionic surfactant(s) may include one or more of the following: peg-30 dipolyhydroxystearate, polyglyceryl-4 diisostearate polyhydroxystearate / sebacate, polyglyceryl-4 isostearate, polyglyceryl-2 dipolyhydroxystearate, and a combination thereof. The nonionic surfactant may be, for example, selected from alcohols, alpha-diols, alkylphenols, and fatty acid esters, wherein these compounds are ethoxylated, propoxylated, or glycerolated and comprise at least one fatty chain comprising, for example, from 14 to 18 carbon atoms. The number of ethylene oxide or propylene oxide groups of the foregoing compounds may vary from 2 to 50, and the number of glycerol groups may vary from 1 to 30.Mention may be made of copolymers of ethylene oxide and / or propylene oxide; condensates of ethylene oxide and / or propylene oxide with fatty alcohols; polyethoxylated fatty amides comprising, for example, from 2 to 30 mol of ethylene oxide; polyglycerolated fatty amides comprising, for example, from 1.5 to 5 glycerol groups, such as from 1.5 to 4; ethoxylated fatty acid esters of sorbitan comprising from 2 to 30 mol of ethylene oxide; ethoxylated oils of vegetable origin; sucrose fatty acid esters; polyethylene glycol fatty acid esters; polyethoxylated glycerol mono or diesters of fatty acids, C15-C24 alkyl(poly)glycosides; N-C15-C24 alkylglucamine derivatives, amine oxides such as C15 alkylamine oxides or N-(C15 acylaminopropylmorpholine) oxides; and mixtures thereof.

[0198] The non-ionic surfactants may be chosen from polyoxyalkylenated or polyglycerolated non-ionic surfactants. The oxyalkylene units are more preferably oxyethylene or oxypropylene units, or a combination thereof, and are preferably oxyethylene units.

[0199] In certain cases, the non-ionic surfactant may be chosen from polyol esters with saturated or unsaturated chain fatty acids containing, for example, from 15 to 24 carbon atoms, preferably from 15 to 22 carbon atoms, and their alkoxylated derivatives, preferably with an alkylene oxide number of 10 to 200, and more preferably from 10 to 100, such as glyceryl esters of one or more C15-C24, preferably C15-C22, fatty acids, and their alkoxylated derivatives, preferably with an alkylene oxide number of 10 to 200, and more preferably from 10 to 100; polyethylene glycol esters of one or more C15-C24, preferably C15-C22, fatty acids and their alkoxylated derivatives, preferably with a number of alkylene oxides of 10 to 200, and more preferably of 10 to 100;sorbitol esters of one or more C15-C24, preferably C15-C22, fatty acids and their alkoxylated derivatives, preferably with a number of alkylene oxides of 10 to 200, and more preferably of 10 to 100; sugar esters (sucrose, glucose, alkylglycose) of one or more C15-C24, preferably C15-C22, fatty acids and their alkoxylated derivatives, preferably with a number of alkylene oxides of 10 to 200, and more preferably of 10 to 100; fatty alcohol ethers; sugar ethers of one or more C15-C24, preferably C15-C22, fatty alcohols; and mixtures thereof. ;

[0200] Examples of ethoxylated fatty esters that may be mentioned include esters of ethylene oxide with esters of palmitic acid, stearic acid or behenic acid, and mixtures thereof, especially those containing from 9 to 100 oxyethylene groups, such as PEG-9 to PEG-50 palmitate (under the CTFA names: PEG-9 palmitate to PEG-50 palmitate); PEG-9 to PEG-50 stearate (under the CTFA names: PEG-9 stearate to PEG-50 stearate); PEG-9 to PEG-50 palmitostearate; PEG-9 to PEG-50 behenate (under the CTFA names: PEG-9 behenate to PEG-50 behenate); Polyethylene glycol monostearate 100 EO (CTFA name: PEG-100 stearate); and mixtures thereof. Examples of fatty acid glyceryl esters include glyceryl stearate (glyceryl mono-, di- and / or tristearate) (CTFA name: glyceryl stearate) or glyceryl ricinoleate and mixtures thereof.Examples of glyceryl esters of C15-C24 alkoxylated fatty acids include polyethoxylated glyceryl stearate (glyceryl mono-, di- and / or tristearate) such as PEG-20 glyceryl stearate (INCI name: PEG-20 STEARATE) marketed under the name MYRJ™ S20 by Croda Home Care. Mixtures of these surfactants, such as the product containing glyceryl stearate and glyceryl stearate. PEG-100 (INCI name: GLYCERYL STEARATE (and) PEG-100 STEARATE), marketed as ARLACEL™ 165 by Croda Inc., and the product containing glyceryl stearate (glyceryl mono- and distearate) and potassium stearate marketed as TEG1N by Goldschmidt (CTFA name: glyceryl stearate SE), may also be used.

[0201] According to a particular embodiment, the composition according to the invention comprises from 0.1% to 10% by weight, preferably from 0.1% to 8% by weight, and more preferably from 0.1% to 5% by weight of additional surfactant(s) relative to the total weight of the composition.

[0202] According to a particular embodiment, a composition according to the invention comprises less than 1.0% by weight, in particular less than 0.5% by weight of silicone surfactant(s) relative to the total weight of the composition, more particularly free of silicone surfactant(s).

[0203] Semi-crystalline polymer(s) containing at least one alkyl acrylate chain

[0204] According to a particular embodiment, the composition according to the invention may comprise at least one semi-crystalline polymer containing at least one alkyl acrylate chain.

[0205] For the purposes of the invention, the term "semi-crystalline polymer" means polymers comprising a crystallizable part, pendant chain or sequence in the skeleton, and an amorphous part in the skeleton, and having a first-order reversible phase change temperature, in particular melting (solid-liquid transition).

[0206] When the crystallizable part is a sequence of the polymer skeleton, this crystallizable sequence is of a chemical nature different from that of the amorphous sequences; the semi-crystalline polymer is in this case a sequenced polymer for example of the diblock, triblock or multiblock type, comprising at least one crystallizable sequence and at least one amorphous sequence.

[0207] By “sequence” we generally mean at least 5 identical repeating units. The crystallizable sequence(s) are then of a different chemical nature from the 5 amorphous sequence(s).

[0208] In particular, the semi-crystalline polymer containing at least one alkyl acrylate chain has an average molecular weight (Mn) greater than or equal to approximately 2000 g / mol, preferably approximately 2000 to 800,000 g / mol, preferably approximately 3000 to 500,000 g / mol, preferably approximately 4000 to 150,000 g / mol, and preferably approximately 4000 to 99,000 g / mol.

[0209] Apart from the crystallizable chains or sequences, the polymer sequences are amorphous.

[0210] By "crystallizable chain or sequence" is meant, within the meaning of the invention, a chain or sequence which, if it were alone, would pass from the amorphous state to the crystalline state, reversibly, depending on whether it is above or below the melting temperature. A chain within the meaning of the invention is a group of atoms, pendant or lateral to the polymer skeleton. A sequence is a group of atoms belonging to the skeleton, a group constituting one of the repeating units of the polymer. Advantageously, the “crystallizable pendant chain” can be a chain comprising at least 6 carbon atoms.

[0211] Preferably, the polymeric backbone of the semi-crystalline polymers is soluble in the oil phase.

[0212] Thus, the semi-crystalline polymer containing at least one alkyl acrylate chain which can be used in a composition according to the invention is generally introduced into the oily phase of the composition.

[0213] Preferably, the crystallizable sequences or chains of the semi-crystalline polymers containing at least one alkyl acrylate chain represent at least approximately 30% by weight and preferably at least approximately 40% by weight relative to the total weight of each polymer.

[0214] In particular, the semi-crystalline polymers with crystallizable sequences that can be used in a composition according to the invention are block or multi-block polymers. They can be obtained by polymerization of monomers with reactive (or ethylenic) double bonds or by polycondensation. When the polymers of the invention are polymers with crystallizable side chains, they are advantageously in random or statistical form.

[0215] For example, the semi-crystalline polymers that can be used in a composition according to the invention are of synthetic origin. Furthermore, they do not comprise a polysaccharide backbone.

[0216] In particular, semi-crystalline polymers may or may not be partially crosslinked. This may then involve chemical crosslinking, by reaction with a multifunctional monomer during polymerization. It may also involve physical crosslinking which may then be due either to the establishment of hydrogen or dipolar bonds between groups carried by the polymer such as dipolar interactions between carboxylate ionomers, these interactions being in small quantity and carried by the polymer skeleton; or to a phase separation between the crystallizable sequences and the amorphous sequences, carried by the polymer.

[0217] Preferably, the semi-crystalline polymers containing at least one alkyl acrylate chain are non-crosslinked.

[0218] As an example of semi-crystalline polymers containing at least one alkyl acrylate chain, mention may be made of those resulting from the polymerization of one or more saturated alkyl (meth)acrylates.

[0219] Preferably, the semi-crystalline polymers with a crystallizable side chain are homopolymers of alkyl(meth)acrylate, or copolymers of these monomers with a hydrophilic monomer.

[0220] According to a particular embodiment, the semi-crystalline polymer containing at least one alkyl acrylate chain is derived from a monomer with a crystallizable chain chosen from saturated alkyl (meth)acrylates, and even more particularly poly(stearyl acrylate) or poly(behenyl acrylate).

[0221] According to another particular embodiment of the invention, the semi-crystalline polymer containing at least one alkyl acrylate chain is chosen from copolymers resulting from the polymerization of at least one monomer with a crystallizable chain chosen from saturated alkyl (meth)acrylates.

[0222] Preferably, the semi-crystalline polymer containing at least one alkyl acrylate chain is chosen from homopolymers obtained by polymerization of a monomer chosen from alkyl acrylates and alkyl methacrylates and from copolymers obtained by copolymerization of a monomer chosen from alkyl acrylates and alkyl methacrylates, with a hydrophilic monomer, preferably N-vinylpyrrolidone or a hydroxyethyl (meth)acrylate, and mixtures thereof, even more preferably a hydroxyethyl (meth)acrylate, and mixtures thereof.

[0223] As a particular example of a semi-crystalline polymer, mention may be made of homopolymers obtained by polymerization of a monomer chosen from alkyl acrylates and alkyl methacrylates, preferably from stearyl acrylates and behenyl acrylates, in particular polymers having the INCI name POLY C10-30 ALKYL ACRYLATE such as the product TEGO® SP 13-1 or TEGO® SP 13-1 MB (formerly Intelimer® IPA 13-1) which is a stearyl polyacrylate marketed by the company EVONIK (AIR PRODUCTS), or the product TEGO® SP 13-6 (formerly Intelimer® IPA 13-6) which is a behenyl polymer (behenyl polyacrylate) marketed by the company EVONIK MATERIALS NE-THERLANDS BV

[0224] As a particular example of another semi-crystalline polymer, mention may also be made of the copolymers obtained by copolymerization of a monomer chosen from alkyl acrylates and alkyl methacrylates, with a hydrophilic monomer, preferably a hydroxyethyl (meth)acrylate, in particular the copolymers described in applications FR 3 073 405 and FR 3 073 406, and preferably the copolymers obtained by copolymerization of at least one monomer chosen from alkyl acrylates, preferably from behenyl acrylates, stearyl acrylates, and mixtures thereof, with a hydrophilic monomer such as hydroxyethyl (meth)acrylate and N-vinylpyrrolidone and preferably hydroxyethyl acrylate.

[0225] Preferably, the semi-crystalline polymer containing at least one alkyl acrylate chain is a behenyl acrylate / 2-hydroxyethyl acrylate copolymer, a stearyl acrylate / 2-hydroxyethyl acrylate copolymer and / or a mixture thereof, and in particular the polymer with the INCI name: Poly C12-22 Alkyl Acrylate / Hydroxyethylacrylate Copolymer, notably marketed under the name Tego® SP Senstar by the EVONIK Company.

[0226] According to a preferred embodiment, the semi-crystalline polymer(s) containing at least one alkyl acrylate chain are chosen from a polystearyl acrylate, a polybehenyl acrylate, a copolymer of behenyl acrylate / 2-hydroxyethyl acrylate, a copolymer of stearyl acrylate / 2-hydroxyethyl acrylate, and one of their mixtures, in particular chosen from the polymer with INCI name: Poly C10-30 Alkyl Acrylate, the copolymer with INCI name Cl2-22 Alkyl Acrylate / Hydroxyethylacrylate Copolymer, and their mixtures, more particularly the polymer with INCI name: Poly C10-30 Alkyl Acrylate.

[0227] According to a more preferred embodiment, the semi-crystalline polymer containing at least one alkyl acrylate chain is a polymer with the INCI name: Poly C10-30 Alkyl Acrylate.

[0228] According to a particular embodiment, a composition according to the invention may comprise from 0.01% to 15% by weight, preferably from 0.05% to 12% by weight, more preferably from 0.1% to 10% by weight, and in particular from 0.2% to 5% by weight of semi-crystalline polymer(s) containing at least one alkyl acrylate chain relative to the total weight of the composition. Aqueous phase

[0229] As mentioned previously, a composition according to the invention comprises at least one physiologically acceptable aqueous phase. By "physiologically acceptable" is meant a medium compatible with keratin materials.

[0230] The composition according to the invention is an oil-in-water (O / W) emulsion. The aqueous phase is the continuous phase.

[0231] A composition according to the invention may also comprise at least one water-soluble solvent.

[0232] Non-limiting examples of water-soluble solvents include, for example, glycerin, alcohols such as C1-C30, C1-C15, C1-C10 or C1-C4 alcohols and for example the C1-C5 monoalcohols described above, organic solvents such as polyols (polyhydric alcohols), glycols (for example, butylene glycol, caprylyl glycol, etc.) and a mixture thereof.

[0233] As examples of organic solvents, non-limiting mentions may be made of monoalcohols and polyols such as ethyl alcohol, isopropyl alcohol, propyl alcohol, benzyl alcohol and phenylethyl alcohol, or glycols or glycol ethers such as, for example, monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or their ethers such as, for example, propylene glycol monomethyl ether, butylene glycol, hexylene glycol, dipropylene glycol as well as diethylene glycol alkyl ethers, for example diethylene glycol monoethyl ether or monobutyl ether. Water-soluble solvents may be organic solvents which may be volatile compounds as described above or non-volatile.

[0234] Other non-limiting examples of water-soluble solvents include alkanediols such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl-2,4-pentanediol, caprylyl glycol, 1,2-hexanediol, 1,2-pentanediol, and 4-methyl-1,2-pentanediol; alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol, and isopropanol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether,ethylene glycol monoisopropyl ether, diethylene glycol monoisopropyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, diethylene glycol mono-t-butyl ether, 1-methyl-l-methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-t-butyl ether, propylene glycol mono-n-propyl ether, propylene glycol monoisopropyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether and dipropylene glycol monoisopropyl ether; 2-pyrrolidone, N-methyl-2-pyrrolidone, l,3-dimethyl-2-imidazolidinone, formamide, acetamide, dimethyl sulfoxide, sorbit, sorbitan, acetin, diacetin, triacetin, sulfone and mixtures thereof.

[0235] According to a particular embodiment, the composition according to the invention comprises from 20% to 70% by weight, preferably from 30% to 70% by weight, and more preferably from 40% to 70% by weight of aqueous phase relative to the total weight of the composition.

[0236] It is also noted that the aqueous phase of a composition according to the invention may comprise water-soluble additives such as water-soluble gelling agents. Gelling agent(s)

[0237] The composition according to the invention may also comprise at least one gelling agent. Such a gelling agent may be a rheology modifying and / or stabilizing polymer. In other words, the gelling agent contributes in particular to obtaining a desired consistency of a composition according to the invention. Of course, such an optional addition of gelling agent is carried out without altering the aforementioned advantageous properties of the composition according to the invention, in particular in terms of limiting the formation of white marks on the skin after application, sensation of comfort and perception of powderiness.

[0238] According to one embodiment, the composition according to the invention comprises a hydrophilic gelling agent, for example synthetic or natural.

[0239] By "water-soluble or water-dispersible polymer" is meant polymers which, for example, introduced into an aqueous phase at 25°C, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, in particular having a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%, preferably at least 70%.

[0240] The hydrophilic gelling agent (or thickener) may in particular be chosen from:

[0241] 1) carboxyvinyl polymers

[0242] The composition according to the invention may further comprise at least one carboxyvinyl polymer.

[0243] Among the carboxyvinyl polymers, we can cite those marketed under the following names:

[0244] - Carbopol® from the company Lubrizol or SYNTHALEN® K (INCI name: carbomer) of the company 3V Sigma USA Inc.;

[0245] - Pemulen™ from Lubrizol or CARBOPOL® ULTREZ 21 POLYMER (INCI name: Acrylates / C10-30 alkyl acrylate crosspolymer) from the company Lubrizol;

[0246] - AQUPEC MG N40R (INCI name: Sodium Carbomer) from SUMITOMO company SEIKA;

[0247] - ACULYN™ 88 POLYMER (INCI name: Acrylates / Steareth-20 Methacrylate Crosspolymer) from Dow Chemical Company;

[0248] - ACULYN™ 28 POLYMER (INCI name: Acrylates / Beheneth-25 Methacrylate Copolymer) from Dow Chemical Company; and

[0249] - ARISTOFLEX® Velvet from Clariant (INCI: Polyacrylate Crosspolymer-11).

[0250] According to a particular embodiment, the composition according to the invention comprises at least one carboxyvinyl polymer chosen from a carbomer (INCI name: carbomer), for example SYNTHALEN® K from the company 3V Sigma USA Inc., the compound with the INCI name Acrylates / C 10-30 alkyl acrylate crosspolymer, for example CARBOPOL® ULTREZ 21 POLYMER from Lubrizol, and mixtures thereof.

[0251] According to a particular embodiment, the composition according to the invention comprises from 0.01% to 10% by weight, in particular from 0.02% to 8% by weight, more particularly from 0.05% to 5% by weight of carboxyvinyl polymer(s) relative to the total weight of the composition.

[0252] Carboxyvinyl polymers may also be polyacrylate salts. In particular, they are crosslinked and neutralized polymers, in non-particulate form.

[0253] Mention may also be made of polymers bearing the INCI name sodium polyacrylate such as Cosmedia SP® or crosslinked sodium polyacrylate containing 90% dry matter and 10% water, Cosmedia SPL® or sodium polyacrylate in inverse emulsion containing approximately 60% dry active matter, an oil (hydrogenated polydecene) and a surfactant (PPG-5 Laureth-5), both sold by the company BASF.

[0254] 2) polymers and copolymers of 2-acrylamido 2-methylpropane sulfonic acid (AMPS}, in particular homopolymers or copolymers, crosslinked or non-crosslinked, comprising at least the monomer acrylamido 2-methylpropane sulfonic acid (AMPS), in particular in a form partially or totally neutralized by a mineral base other than ammonia such as sodium hydroxide or potassium hydroxide.

[0255] These AMPS polymers can be completely neutralized or practically completely neutralized, i.e. neutralized to at least 90%.

[0256] These AMPS polymers can be crosslinked or non-crosslinked.

[0257] The AMPS polymers suitable for the invention are hydrophilic, i.e. hydro soluble or water-dispersible. They can be:

[0258] - either “homopolymers” comprising only AMPS monomers and, if they are crosslinked, one or more crosslinking agents such as those defined above;

[0259] - either copolymers obtained from AMPS and one or more monomers for example ethylenically unsaturated, hydrophilic or hydrophobic, and, if crosslinked, one or more crosslinking agents such as those defined below. When said copolymers comprise hydrophobic ethylenically unsaturated monomers, they are preferably present in small amounts.

[0260] The water-soluble or water-dispersible AMPS® polymers preferably have a molar mass ranging from 50,000 g / mol to 10,000,000 g / mol, preferably from 80,000 g / mol to 8,000,000 g / mol, and even more preferably from 100,000 g / mol to 7,000,000 g / mol.

[0261] As water-soluble or water-dispersible homopolymers of AMPS suitable for the invention, mention may be made, for example, of crosslinked or non-crosslinked polymers of sodium 2-acrylamido-2-methyl propane sulfonate acid such as that used in the commercial product SIMULGEL 800 (CTFA name: Sodium Polyacryloyldimethyl Taurate), crosslinked polymers of ammonium 2-acrylamido-2-methyl propane sulfonate acid (INCI name: AMMONIUM POLYACRYLDIMEHYLTAURAMIDE or AMMONIUM POLYACRYLOYLDIMETHYL TAURATE) such as the product sold under the trade name HOSTACERIN AMPS® by the company Clariant.

[0262] As water-soluble or water-dispersible copolymers of AMPS in accordance with the invention, we may cite for example:

[0263] - crosslinked acrylamide / acrylamido-2-methyl propane sulfonate copolymers of sodium such as that used in the commercial product SEPIGEL 305 (CTFA name: POLYACRYLAMIDE / C13-C14 ISOPARAFFIN / LAURETH-7) or that used in the commercial product sold under the name SIMULGEL 600 (CTFA name: ACRYLAMIDE / SODIUM ACRYLOYLDIMETHYLTAURATE / ISO-HEXADECANE / POLYSORBATE-80) by the company SEPPIC;

[0264] - copolymers of AMPS® and vinylpyrrolidone or vinylformamide such as that used in the commercial product sold under the name ARISTOFLEX AVC® by the company CLARIANT (CTFA name: AMMONIUM ACRYLOYLDIME-THYLTAURATE / VP COPOLYMER) but neutralized by soda or potash;

[0265] - copolymers of AMPS® and sodium acrylate, such as for example co AMPS / sodium acrylate polymer such as that used in the commercial product sold under the name SIMULGEL EG® by the company SEPPIC or under the trade name SEPINOV EM (CTFA name: HYDROXYETHYL ACRYLATE / SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER);

[0266] - copolymers of AMPS® and hydroxyethyl acrylate, such as for example co AMPS® / hydroxyethyl acrylate polymer such as that used in the commercial product sold under the name SIMULGEL NS® by the company SEPPIC (CTFA name: HYDROXYETHYL ACRYLATE / SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (AND) SQUALANE (AND) POLYSORBATE 60) or as the product marketed under the name COPOLYMER ACRYLAMIDO-2-METHYL PROPANE SULFONATE DE SODIUM / HY-DROXYETHYLACRYLATE such as the commercial product SEPINOV EMT 10 (INCI name: HYDROXYETHYL ACRYLATE / SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER);

[0267] - copolymers of AMPS® and ethoxylated cetearyl methacrylate, even actually crosslinked, such as Aristoflex® HMS, which is called AMPS / ethoxylated cetearyl methacrylate (25 EO) 80 / 20 copolymer, crosslinked by trimethylolpropane triacrylate (TMPTA) or Ammonium Acryloyldimethyltaurate / Steareth-25 methacrylate crosspolymer in the INCI name.

[0268] According to a particular embodiment, the composition according to the invention comprises at least one polymer of 2-acrylamido 2-methylpropane sulfonic acid (AMPS), in particular chosen from crosslinked polymers of ammonium 2-acrylamido-2-methyl propane sulfonate acid (INCI name: AMMONIUM POLYACRYLDIMETHYL-TAURAMIDE or AMMONIUM POLYACRYLOYLDIMETHYL TAURATE), plus particularly the product sold under the trade name HOSTACERIN AMPS® by the company Clariant.

[0269] According to a particular embodiment, the composition according to the invention comprises from 0.01% to 10% by weight, in particular from 0.02% to 8% by weight, more particularly from 0.05% to 5% by weight of 2-acrylamido 2-methylpropane sulfonic acid (AMPS) polymer(s) relative to the total weight of the composition. Oily phase

[0270] An “oil phase” is a phase comprising at least one oil which may include additional fat-soluble and lipophilic ingredients.

[0271] The oils included in the oily phase may be volatile or non-volatile.

[0272] The term “non-volatile oil” relates to an oil which remains on the skin or keratinous fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10-3 mmHg (0.13 Pa).

[0273] The composition according to the invention may contain non-volatile oils but these must of course not impact the desired properties, in particular in terms of limiting the formation of white traces on the skin after application, sensation of comfort and perception of powderiness.

[0274] According to one embodiment, the composition according to the invention comprises one or more non-volatile hydrocarbon-based oils distinct from squalane (b), alkane oil(s) (c) and fatty alcohol(s) (d).

[0275] For example, the non-volatile hydrocarbon-based oil may be a saturated hydrocarbon, an unsaturated hydrocarbon, lipids, triglycerides, a natural oil, and / or a synthetic oil.

[0276] Mention may be made of non-volatile hydrocarbon-based oils, distinct from squalane (b), from alkane oil(s) (c) and from fatty alcohol(s) (d), such as for example:

[0277] (i) hydrocarbon-based oils of vegetable origin, such as triesters of glycerides, which are generally triesters of fatty acids and glycerol, the fatty acids of which may have chain lengths varying from C4 to C24, the latter being able to be linear or branched, saturated or unsaturated; These oils include wheat germ, rice bran, sunflower, grape seed, sesame, corn, apricot, castor, shea, avocado, olive, soybean, sweet almond, palm, rapeseed, cottonseed, hazelnut, macadamia, alfalfa, poppy, pumpkin, sesame, squash, rapeseed, blackcurrant, evening primrose, millet, barley, quinoa, rye, safflower, candlenut, passionflower, musk rose, Limanthes alba seeds (INCI name: Limnanthes Alba (Meadowfoam) Seed Oil); or caprylic / capric acid triglycerides such as those sold by the company Stéarineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel. We can also cite coco-caprylate / caprate, for example marketed under the name Cetiol LC by the company Cognis or under the name DUB 810 C by the company Stearinerie Dubois;

[0278] (ii) synthetic ethers containing from 10 to 40 carbon atoms;

[0279] (iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam;

[0280] (iv) synthetic esters, for example oils of formula RCOOR' in which R represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms and R' represents a hydrocarbon chain which is in particular branched, containing from 1 to 40 carbon atoms provided that R+R' is > 10, for example Purcellin oil (cetearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoate, such as the product marketed under the name Finsolv TN® or Witconol TN® by Witco or Tegosoft TN® by Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the product marketed under the name X-Tend 226 by ISP, isopropyl lanolate, hexyl laurate, adipate dii-isopropyl, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate, such as the product sold under the name "Dub Dis" by Stearinerie Dubois, octanoates,decanoates or ricinoleates of alcohols or polyalcohols, such as propylene glycol dioctanoate; hydroxylated esters, such as for example isostearyl lactate or diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as for example di(C12-C13 linear alkyl) tartrates, such as those sold under the name Cosmacol ETI® by Enichem Augusta Industriale, and also di(C14-C15 linear alkyl) tartrates, such as those sold under the name Cosmacol ETL® by the same company; or acetates; ,

[0281] (v) higher fatty acids C19-C22;

[0282] (vi) carbonates, such as for example dicaprylyl carbonate, such as the product sold under the name Cetiol CC® by Cognis;

[0283] (viii) fatty amides, such as for example isopropyl N-lauroyl sarcosinate, such as the product sold under the trade name Eldew SL 205® from Ajinomoto; and

[0284] (iv) mixtures thereof.

[0285] According to a particular embodiment, the oily phase of the composition according to the invention comprises one or more non-silicone oils, such as the aforementioned volatile hydrocarbon oils, the aforementioned non-volatile hydrocarbon-based oils and mixtures thereof.

[0286] Preferably, a composition according to the invention comprises less than 1.0% by weight, in particular less than 0.5% by weight of silicone oil(s) relative to the total weight of the composition, more particularly free of silicone oil(s).

[0287] According to a particular embodiment, the composition according to the invention comprises from 5% to 40% by weight, preferably from 10% to 35% by weight, more preferably from 15% to 30% by weight of oily phase relative to the total weight of the composition. Cosmetic composition

[0288] The composition used according to the invention can be presented in all the galenic forms normally used in the cosmetic field.

[0289] It can be more or less fluid and have the appearance of a gel, a white or colored cream, an ointment, a milk, a lotion, a serum, a paste.

[0290] More particularly, the composition according to the invention is intended for application to the skin. This may be the skin of the face and / or the body, in particular the face and / or the neck and / or the hands.

[0291] The composition according to the invention may comprise all the constituents usually used in the application and topical administration envisaged.

[0292] Preferably, such a composition is not intended to be rinsed after application. Cosmetic active ingredients and adjuvants

[0293] The compositions according to the present invention may of course contain one or more active ingredients and adjuvants chosen in particular from cosmetic active ingredients, in particular active ingredients for the skin, sunscreens, colorants, pearlescent agents, pigments, perfumes, preservatives, pH adjusters, film-forming agents, fillers additional to hydrophilic silica, etc. Of course, the person skilled in the art will take care to choose this or these possible additional compounds and / or their quantity in such a way that the advantageous properties of the composition according to the invention are not, or not substantially, altered by the envisaged addition.

[0294] For example, a composition according to the invention may comprise one or more preservatives, one or more pH correctors (for example, sodium and / or potassium hydroxide), one or more perfumes, one or more salts, one or more colorants and / or dyes, one or more preservatives (for example, chlorphenesin).

[0295] Non-limiting examples of skin active ingredients include anti-aging agents, depigmenting agents, anti-wrinkle agents, agents for treating oily skin, mattifying agents, antioxidants, vitamins, anti-acne agents, anti-inflammatory agents and electrolytes.

[0296] According to a particular embodiment, the composition according to the invention comprises less than 2% by weight of pigment(s) relative to the total weight of the composition.

[0297] According to another particular embodiment, the composition according to the invention comprises less than 1% by weight, in particular less than 0.5% by weight of UV filter(s) relative to the total weight of the composition, and more particularly free of UV filter(s).

[0298] According to another particular embodiment, the composition according to the invention comprises less than 0.5% by weight of iron oxide relative to the total weight of the composition, in particular free of iron oxide. Uses and methods

[0299] According to one of its aspects, the present invention relates to the use of a composition as defined above in the cosmetic field, and in particular for the care and / or protection of the skin of the body or face.

[0300] According to another of its aspects, the present invention relates to a method for the cosmetic treatment of a keratin material in which a composition as defined in the present invention is applied to the keratin material.

[0301] The cosmetic uses and processes considered according to the invention are non-therapeutic.

[0302] The cosmetic use or process of the invention is implemented by administering topically a composition according to the invention.

[0303] Topical administration consists of the external application to the skin of cosmetic compositions according to the usual techniques of use of these compositions.

[0304] By way of illustration, the cosmetic use or process according to the invention can be implemented by topical application, for example daily, of at least one composition according to the invention, which can be for example formulated in the form of a gel, a white or colored cream, an ointment, a milk, a lotion, a serum, a paste.

[0305] According to one embodiment, the application is repeated for example 1 to 2 times daily over one day or more and generally over a prolonged period of at least 4, or even 4 to 15 weeks, with, where appropriate, one or more periods of interruption.

[0306] According to one embodiment, the application is daily (once a day) and generally over a prolonged period of at least 4, or even 4 to 15 weeks, with, where appropriate, one or more periods of interruption.

[0307] According to an alternative embodiment, the composition according to the invention will be applied to areas of skin previously cleaned using a washing solution.

[0308] Throughout the description, including the claims, the expressions "between ... and ..." and "ranging from ... to ..." must be understood inclusively, unless otherwise specified.

[0309] In the examples, unless otherwise indicated, the quantities of the ingredients of the com positions are expressed in % by weight of raw material relative to the total weight of composition. Examples MATERIALS AND METHODS Raw materials

[0310] In the examples below the compounds are identified by their INCI name:

[0311] “DECYL GLUCOSIDE” is marketed under the name PLANTACARE® 2000 UP by the company BASF (at 53% by weight of active ingredient relative to the total weight of raw material);

[0312] “SODIUM DILAURAMIDOGLUTAMIDE LYSINE” is marketed under the name PELLICER™ LB-30G by the company ASAHI KASEI (at 27.3% by weight of active material relative to the total weight of raw material);

[0313] “GLYCERYL STEARATE (and) PEG-100 STEARATE” is marketed under the name ARLACEL™ 165 by Croda Inc.;

[0314] “PEG-20 STEARATE” is marketed under the name MYRJ™ S20 by the company Croda Home Care;

[0315] “C9-12 ALKANE” is marketed under the name VEGELIGHT® SILK 100 by the company BIOSYNTHIS;

[0316] “AMMONIUM POLYACRYLOYLDIMETHYL TAURATE” is marketed under the name HOSTACERIN® AMPS by the company Clariant;

[0317] “ACRYLATES / C10-30 ALKYL ACRYLATE CROSSPOLYMER” is marketed under the name CARBOPOL® ULTREZ 21 POLYMER by the company Lubrizol;

[0318] “SILICA” is marketed under the name SUNSPHERE® H51 by the company AGC SI TECH;

[0319] “OCTYLDODECANOL” is marketed under the name EUTANOL® G, EUTANOL® G-JP or EUTANOL® G / MB by the company BASF or under the name ISOFOL® 20 by the company SASOL;

[0320] “SQUALANE” marketed under the name EXOLIVE® by the company CAROI LINE COSMETICA, under the name OLIVE SQUALANE by the company EFP BIOTEK, under the name PLANTASENS® OLIVE SQUALANE by the company CLARIANT or under the name SQUALIVE® by the company BIOSYNTHIS; and

[0321] “POLY C10-30 ALKYL ACRYLATE” is marketed under the name TEGO® SP 13-1 by the company EVONIK (AIR PRODUCTS). Sensory evaluation protocol

[0322] Technical effects relating to sensoriality after application of a composition, particularly with regard to the feeling of comfort and the powdery effect, were highlighted via the following protocol carried out by five evaluators:

[0323] - application of a defined quantity of a composition, corresponding to 0.2 g, on the back of the hand;

[0324] - spreading the composition in a circular and uniform manner on the back of the hand by completing 15 laps in 15 seconds; and

[0325] - evaluation of comfort and powdered effect at 2 minutes 30 seconds after application of the composition.

[0326] Protocol for evaluating the formation of white marks on the skin

[0327] This technical effect was demonstrated via the following protocol:

[0328] - application of a defined quantity of a composition, corresponding to 0.2 g, on the back of the hand;

[0329] - spreading the composition in a circular and uniform manner on the back of the hand by completing 15 laps in 15 seconds; and

[0330] - visual assessment of the formation of white traces on the skin 10 minutes later application of the composition, then rating of the composition according to a whitening scale, the rating of “0” is given when no whitening is observed, the rating of “1” is given for slight whitening, and the rating of “2” is given for severe whitening.

[0331] Example 1 - Preparation of the compositions according to the invention and comparison

[0332] A composition according to the invention (II) and a composition outside the invention (Cl) devoid of squalane (b), were prepared according to the preparation protocol described below with the nature of the ingredients and their respective quantities given in table 1. The contents are expressed as a percentage by weight relative to the total weight of the composition. Process for preparing the compositions

[0333] In a Raynerie mixer equipped with a rotor / stator and deflocculator, the components of phase A are mixed followed by the addition of boiling water to the mixture obtained.

[0334] The components of phase B1 are heated to 75-85°C (melting of the fats). The mixture obtained is added to phase A with rotor / stator stirring (1300 rpm) without heating. The mixture obtained is cooled to a temperature below 55°C followed by the addition of phase B2 with rotor / stator stirring. The resulting emulsion is checked under a microscope after 10 minutes. The components of phase C are added to the emulsion while stirring using the deflocculator. The resulting mixture is cooled to a temperature below 30°C. The components of phase D are added in portions to the emulsion cooled by an ice bath and stirred using the deflocculator. Phase E is added to the mixture while stirring using the deflocculator so that the temperature remains below 30°C.

[0335] [Tables 1] Phase INCI(US) The (invention) Cl (outside the invention) TO WATER Qsp 100 Qsp 100 TO GLYCERIN 7.00 7.00 TO PRESERVATIVES 0.97 0.97 TO DECYL GLUCOSIDE 3.70 DIDOYLUMIUM SODIUM LYSINE 0.35 0.35 ANTI-AGING ACTIVE A 2.64 2.64 CHELATING A 0.10 0.10 GLYCOL 3.00 3.00' BI GLYCERYL STEARATE (and) PEG-10Q 1,2070 STEARATE ANT-AGE ACTIVE Stearate 1.20 L20 0.10 0.10 ISONONYLISONONANOATE - 2.50 LIMNANTHS ALBA (MEADOWOAM) SEED OIL 2.00 2.00 OXTIEY - 2.55 SQUALAN 0.07 0.07 B .DICAPRYLYL CARBONATE 3.50 3.50 B STEARYL ALCOHOL 1.50 1.50 B DEPENTAERYTHRITYL HEXACAPRYLATEHEXACAPRATE 1.30 L30 / DAY / DAY PHYTOSTERYL DIMER DïLINOLEYL LIME DILINOLEATE 1.50 1.50 BY OCTYLDODECANOL 0.S5 0.85 BY POLY C1Ô-3Q ALKYL ACRYLATE 1.00 1.00 B2 CMS 10.00 ALKA AMMONK^IPOLYACRYLOYLDIMETHYL TAURATE 0.8S (US D SILICA 22.00 22.00 E ALCOHOL DENAT. 1.00 1.00 Formation of white traces 1 2

[0336] The sensation of comfort and powdery effect was characterized upon application for composition II according to the invention following the evaluation protocol described above. It is found that composition II according to the invention is satisfactory in terms of comfort and powdery effect.

[0337] The formation of white traces on the skin was also characterized (Table 1) after application, for composition II according to the invention and composition Cl excluding invention, following the evaluation protocol described above.

[0338] It is found that for composition II according to the invention, the formation of white traces on the skin is significantly limited unlike comparative composition Cl.

Claims

Claims

1. Composition, preferably cosmetic, in the form of an oil-in-water emulsion, comprising: (a) at least one hydrophilic silica; (b) at least one squalane; (c) at least one alkane oil with a molecular weight less than or equal to 200 g / mol; and (d) at least one C6-C3o fatty alcohol, liquid at room temperature.

2. A composition according to claim 1, wherein said hydrophilic silica (a) is amorphous.

3. Composition according to any one of claims 1 or 2, wherein said hydrophilic silica (a) is chosen from silicas having an average particle diameter ranging from 1 pm to 30 pm, in particular from 1 pm to 25 pm, and more particularly from 1 pm to 20 pm.

4. Composition according to any one of the preceding claims, comprising at least 7% by weight, in particular at least 10% by weight, more particularly at least 12% by weight, and even more particularly 14% by weight of hydrophilic silica(s) (a) relative to the total weight of the composition.

5. Composition according to any one of the preceding claims, comprising from 0.01% to 20% by weight, preferably from 0.1% to 15% by weight, and more preferably from 0.5% to 10% by weight of squalane (b) relative to the total weight of the composition.

6. Composition according to any one of the preceding claims, comprising at least one alkane oil (c) chosen from C6 to C14 alkane oils, preferably C8 to C12 alkane oils, more preferably C9 to C12 alkane oils, and in particular C9 to C12 alkane oils.

7. Composition according to any one of the preceding claims, wherein said alkane oil (c) comprises at least one mixture of C6-Ci4 alkane oils, in particular C8-Cn alkane oils, more particularly C9-Cb alkane oils, and in particular C9-Ci2 alkane oils.

8. Composition according to any one of the preceding claims, comprising from 5% to 35% by weight, preferably from 5% to 25% by weight, more preferably from 5% to 20% by weight, and in particular from 5% to 15% by weight of alkane oil(s) (c) relative to the total weight of the composition.

9. Composition according to any one of the preceding claims, said fatty alcohol (d) being chosen from liquid C16-C22 fatty alcohols and their mixtures, and in particular from C18-C20 fatty alcohols and their mixtures, and more particularly being at least octyldodecanol.

10. Composition according to any one of the preceding claims, comprising from 0.01% to 15% by weight, preferably from 0.1% to 5% by weight, and in particular from 0.5% to 2% by weight of fatty alcohol(s) (d) relative to the total weight of the composition.

11. Composition according to any one of the preceding claims comprising: - at least 7% by weight of hydrophilic silica(s) (a) relative to the total weight of the composition; - from 5% to 35% by weight of alkane oil(s) (c) relative to the total weight of the composition, including at least one mixture of C 9-C 12 alkane oils; - from 0.01% to 20% by weight of squalane (c) relative to the total weight of the composition; and - from 0.01% to 10% by weight of fatty alcohol(s) (d) relative to the total weight of the composition, including at least octyldodecanol.

12. Composition according to any one of the preceding claims, comprising from 20% to 70% by weight, preferably from 30% to 70% by weight, and more preferably from 40% to 70% by weight of aqueous phase relative to the total weight of the composition.

13. Composition according to any one of the preceding claims, comprising less than 1.0% by weight, in particular less than 0.5% by weight of silicone compound(s) relative to the total weight of the composition, and more particularly free of silicone compound(s).

14. Process for the cosmetic treatment of a keratin material in which a composition as defined in any one of the preceding claims is applied to the keratin material.

15. Use of a composition as defined in any one of claims 1 to 13, in the cosmetic field, and in particular for the care and / or protection of the skin of the body or face.